CD19 and neoplasm: Notably, in the non‐tumor‐bearing mice, no abnormal clinical symptoms, pathological changes or deaths were observed throughout the study period, regardless of whether they were treated with CD19‐CAR‐DNTs or freezing buffer (Supplementary tables 1–4, Figure 8a).